US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Veraxa Biotech Holding AG

1.20

+0.120011.11%

Post-market: 1.220.0200+1.67%19:37 EDT

Volume:751.58K

Turnover:919.42K

Market Cap:169.69M

PE:5.60

High:1.32

Open:1.16

Low:1.10

Close:1.08

52wk High:27.36

52wk Low:1.04

Shares:141.41M

Float Shares:36.77M

Volume Ratio:4.25

T/O Rate:2.04%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.2142

EPS(LYR):-5.8037

ROE:-871.42%

ROA:-49.99%

PB:-8.97

PE(LYR):-0.21

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

VERAXA Biotech (NASDAQ: VRXA) Advances FDA-Aligned Methods to Reduce Animal Testing

Micro-Cap Stock Veraxa Biotech is Down 96% This Year. Can Next-Gen Drug Testing Save It?

Veraxa Biotech Expands FDA-Aligned Non-Animal Testing Models, Aiming to Cut Animal Use in Oncology R&D

Veraxa Biotech Provides Overview on Implementation of FDA-Aligned Human-Relevant Models into R&D Strategy

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/VRXA"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"VRXA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRXA\",,,,,undefined,":{"symbol":"VRXA","market":"US","secType":"STK","nameCN":"Veraxa Biotech Holding AG","latestPrice":1.2,"timestamp":1791403200000,"preClose":1.08,"halted":0,"volume":751576,"hourTrading":{"tag":"盘后","latestPrice":1.22,"preClose":1.2,"latestTime":"19:37 EDT","volume":23375,"amount":27177.388,"timestamp":1791416255328,"change":0.02,"changeRate":0.016667,"amplitude":0.08275},"delay":0,"changeRate":0.111111111111111,"floatShares":36767500,"shares":141407813,"eps":0.2142,"marketStatus":"Closed","change":0.12,"latestTime":"10-07 16:00:00 EDT","open":1.16,"high":1.32,"low":1.1001,"amount":919423.8146128,"amplitude":0.203611,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.2142,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791446400000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":1.08,"preHourTrading":{"tag":"盘前","latestPrice":1.1448,"preClose":1.08,"latestTime":"09:29 EDT","volume":36080,"amount":42249.665568000004,"timestamp":1791379766006,"change":0.0648,"changeRate":0.06,"amplitude":0.148148},"postHourTrading":{"tag":"盘后","latestPrice":1.22,"preClose":1.2,"latestTime":"19:37 EDT","volume":23375,"amount":27177.388,"timestamp":1791416255328,"change":0.02,"changeRate":0.016667,"amplitude":0.08275},"volumeRatio":4.247085},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRXA\",,,,,undefined,":{"symbol":"VRXA","floatShares":36767500,"roa":"-49.99%","roe":"-871.42%","lyrEps":-5.803658,"volumeRatio":4.247085,"shares":141407813,"dividePrice":0,"high":1.32,"amplitude":0.203611,"preClose":1.08,"low":1.1001,"week52Low":1.04,"pbRate":"-8.97","psRate":"6033.98","week52High":27.36,"institutionHeld":0,"latestPrice":1.2,"eps":0.2142,"divideRate":0,"volume":751576,"delay":0,"ttmEps":0.2142,"open":1.16,"prevYearClose":18.65,"prevWeekClose":1.13,"prevMonthClose":1.25,"prevQuarterClose":1.25,"fiveDayClose":1.25,"twentyDayClose":1.59,"sixtyDayClose":2.09},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VRXA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VRXA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VRXA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VRXA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VRXA","date":"2026-10-06","current":5.602241,"percent":0.6875,"low":-3.022108,"twenty":-2.642672,"median":-2.428312,"eighty":-1.301404,"high":-0.413162,"avg":-2.058731,"sd":0.759084,"marketCap":159790828},"quantilePoints":[{"date":"2026-08-21","current":-1.35335,"twenty":-1.349054,"median":-1.34261,"eighty":-1.336165,"marketCap":47660725},{"date":"2026-08-28","current":-1.03732,"twenty":-1.349054,"median":-1.281094,"eighty":-1.194963,"marketCap":36312933},{"date":"2026-09-04","current":-2.622384,"twenty":-1.391748,"median":-1.265172,"eighty":-0.552029,"marketCap":216353953},{"date":"2026-09-11","current":-2.842124,"twenty":-2.738773,"median":-1.34261,"eighty":-1.03732,"marketCap":233322891},{"date":"2026-09-18","current":-2.57236,"twenty":-2.751957,"median":-2.365287,"eighty":-1.181392,"marketCap":207869485},{"date":"2026-09-25","current":-2.481882,"twenty":-2.738773,"median":-2.472656,"eighty":-1.249249,"marketCap":199385016},{"date":"2026-10-02","current":-2.09825,"twenty":-2.642883,"median":-2.446678,"eighty":-1.281094,"marketCap":168275297},{"date":"2026-10-06","current":-1.992696,"twenty":-2.642672,"median":-2.428312,"eighty":-1.301404,"marketCap":159790828}],"updateTime":1791420025125},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VRXA\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673014180","title":"VERAXA Biotech (NASDAQ: VRXA) Advances FDA-Aligned Methods to Reduce Animal Testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2673014180","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673014180?lang=en_us&edition=fundamental","pubTime":"2026-10-08 01:00","pubTimestamp":1791392422,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, October 7th, 2026, FinanceWire VERAXA Biotech (NASDAQ:VRXA), a developer of next-generation antibody-based cancer the...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/veraxa-biotech-nasdaq-vrxa-advances-fda-aligned-methods-to-reduce-animal-testing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/veraxa-biotech-nasdaq-vrxa-advances-fda-aligned-methods-to-reduce-animal-testing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NDX","BK4139","JEPQ","BK4588","XBI","NVIW.SI","NQmain","TQQQ","LABU","BK4581","QYLG","QQQ","QID","GPIQ","TQQY","QQQM",".IXIC","BK4585","MNQmain","FTEC","PSQ","QQQA","QDTE","QQQE","03086","TECS","QQQJ","QLD","VRXA","SQQQ","QQQY","IYW","ONEQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673013460","title":"Micro-Cap Stock Veraxa Biotech is Down 96% This Year. Can Next-Gen Drug Testing Save It?","url":"https://stock-news.laohu8.com/highlight/detail?id=2673013460","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673013460?lang=en_us&edition=fundamental","pubTime":"2026-10-07 21:09","pubTimestamp":1791378540,"startTime":"0","endTime":"0","summary":"Since going public, Veraxa Biotech has endured a deep slump that has pushed its stock into single-digit territory. Its recovery may hinge on the adoption of new drug-testing protocols to accelerate it","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965509101.SGD","AZNH","LU0456855351.SGD","LU1923622614.USD","AZN","BK4566","LU1162221912.USD","LU0912757837.SGD","IE00B19Z3581.USD","IYH","RXL","JDOC","VRXA","IE00BN8TJ469.HKD","MEDX","LU1839511570.USD","ABBV","LU2456880835.USD","SG9999001440.SGD","LU1934455194.USD","BK4581","LU1929549753.HKD","LU2089284900.SGD","LU1720051017.SGD","LU0198837287.USD","XLV","BK4534","TRUH","PJP","GLAM","LU0949170772.SGD","LU1720051108.HKD","PPH","AGNG","IE00B3PB1722.GBP","LU1057294990.SGD","LU2133065610.SGD","IE00BLSP4452.SGD","LU0942090050.USD","XBI","FTXH","IXJ","LU0122379950.USD","VHT","LU2125909247.SGD","FHLC","LU0114720955.EUR","LU2237443465.HKD","LU1829250122.USD","LU0708994859.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673109209","title":"Veraxa Biotech Expands FDA-Aligned Non-Animal Testing Models, Aiming to Cut Animal Use in Oncology R&D","url":"https://stock-news.laohu8.com/highlight/detail?id=2673109209","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673109209?lang=en_us&edition=fundamental","pubTime":"2026-10-07 19:00","pubTimestamp":1791370854,"startTime":"0","endTime":"0","summary":"Veraxa Biotech expands FDA-aligned non-animal testing models, aiming to cut animal use in oncology R&DVeraxa outlined an ESG-linked shift to FDA-aligned New Approach Methodologies to cut animal testin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nNDL8MQ7sC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRXA","IE00BN0W2V16.EUR","SG9999014013.SGD","SG9999014021.USD","SG9999014039.USD","LU2095319765.USD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","BCDF","IE00B64PRP62.GBP","IE00BQXX3F31.USD","LU2210149790.SGD","BK4588","IE00BKPKM429.USD","LU2210150020.SGD","IE00BQXX3C00.GBP","NDAQ","BK4585","SG9999014005.SGD","BK4139","BK4112","IE00BQXX3D17.EUR","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673409206","title":"Veraxa Biotech Provides Overview on Implementation of FDA-Aligned Human-Relevant Models into R&D Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2673409206","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673409206?lang=en_us&edition=fundamental","pubTime":"2026-10-07 19:00","pubTimestamp":1791370800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nTUAB2KMJN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VRXA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":20,"pageCount":1,"totalSize":80,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/VRXA\",params:#limit:6,delay:false,,,undefined,":[]}}